openPR Logo
Press release

Insights on the Global Age-Related Macular Degeneration Therapeutics Market to 2027 | Industry Statistics, Emerging Demands, Forecast to 2027

01-12-2022 12:44 PM CET | Health & Medicine

Press release from: Orion Market Research

The global age-related macular degeneration therapeutics market is expected to grow at a significant CAGR during the forecast period (2021-2027). Age-related macular degeneration (AMD), commonly known as macular degeneration, is a disorder in which the macula of the retina thins, resulting in loss of central vision. Age-related macular degeneration is most common in the elderly population and can result in permanent visual loss in those aged 60 and up.

Dry age-related macular degeneration (Dry AMD) and wet age-related macular degeneration (Wet AMD) are the two kinds of age-related macular degeneration (wet AMD). Dry age-related macular degeneration is the most prevalent type of macular degeneration, in which the macula thins with age and central vision is lost. Dry age-related macular degeneration does not have a treatment. The less prevalent variety of age-related macular degeneration is wet age-related macular degeneration, which is marked by the proliferation of aberrant blood vessels behind the retina. Anti-vascular endothelial growth factor (anti-VEGF) injections can be used to treat wet age-related macular degeneration.

To Request a Sample of our Report on Global Age-Related Macular Degeneration Therapeutics Market: https://www.omrglobal.com/request-sample/age-related-macular-degeneration-therapeutics-market

During the forecast period, the global age-related macular degeneration therapeutics market is expected to be driven by an increase in the geriatric population. According to the World Population Prospects report from 2017, the global population over 60 years old was 962 million, with a projected increase to roughly 2.1 billion by 2050. Globally, the population of people aged 60 and over is growing at a greater rate than all other age categories. This population is particularly vulnerable to age-related disorders such as diabetes, renal insufficiency, arthritis, and macular degeneration. People between the ages of 50 and 59 have a 2% chance of developing advanced age-related macular degeneration, however, those above the age of 75 have a 30% chance. Therefore, the rising prevalence of age-related macular degeneration is expected to boost the market growth.

Market Coverage

· The market number available for – 2020-2027

· Base year- 2020

· Forecast period- 2021-2027

· Segment Covered

· Regions Covered- Globally

· Competitive Landscape: Novartis International AG, Bayer AG, Regeneron Pharmaceuticals, Inc., F. Hoffmann-La Roche Ltd. Pfizer Inc., Amgen Inc among others.

(Get 15% Discount on Buying this Report)

A full Report of Global Age-Related Macular Degeneration Therapeutics Market is Available at: https://www.omrglobal.com/industry-reports/age-related-macular-degeneration-therapeutics-market

Global Age-Related Macular Degeneration Therapeutics Market Report Segmentation

By Type

• Dry Age-Related Macular Degeneration

• Wet Age-Related Macular Degeneration

By Distribution Channel

• Hospital Pharmacies

• Retail Pharmacies

• Online Pharmacies

By Drug Type

• Brolucizumab

• Bevacizumab

• Ranibizumab

• Pegaptanib

• Aflibercept

• Others

Global Age-Related Macular Degeneration Therapeutics Market by Region

North America

· United States

· Canada

Europe

· UK

· Germany

· Spain

· France

· Italy

· Rest of Europe

Asia-Pacific

· India

· China

· Japan

· South Korea

· Rest of APAC

Rest of the World

Reasons to buy from us –

1. We cover more than 15 major industries, further segmented into more than 90 sectors.

2. More than 120 countries are for analysis.

3. Over 100+ paid data sources mined for investigation.

4. Our expert research analysts answer all your questions before and after purchasing your report.

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Insights on the Global Age-Related Macular Degeneration Therapeutics Market to 2027 | Industry Statistics, Emerging Demands, Forecast to 2027 here

News-ID: 2524880 • Views:

More Releases from Orion Market Research

Infrastructure as Code (IaC) Service Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
Infrastructure as Code (IaC) Service Market Size Analysis, Competitive Insights, …
Infrastructure as Code (IaC) Service Market was valued at approximately USD 0.932 billion, and it's projected to expand to around USD 7.509 billion by 2033, achieving a robust CAGR of 23.2% from 2024 to 2033. Infrastructure as Code (IaC) Service Market Overview The Infrastructure as Code (IaC) Service Market is experiencing remarkable expansion, fueled by the escalating need for scalable, automated infrastructure deployment across cloud and enterprise environments. In 2023, the market
Ultra High-Performance Liquid Chromatography (UHPLC) Columns Market : A Guide to Understanding the Process
Ultra High-Performance Liquid Chromatography (UHPLC) Columns Market : A Guide to …
Ultra High‐Performance Liquid Chromatography (UHPLC) Columns Market is estimated to be valued at USD 2.5 billion, and is projected to grow to approximately USD 4.8 billion by 2033, representing a compound annual growth rate (CAGR) of about 7.8% from 2024 to 2033. Ultra High-Performance Liquid Chromatography (UHPLC) Columns Market Overview The UHPLC columns market is on a strong growth trajectory, fueled by increasing demand for rapid, high-resolution analytical techniques across pharmaceuticals, biotechnology,
Property Management Service Market Rising Demand and Growth Forecast Through 2033
Property Management Service Market Rising Demand and Growth Forecast Through 203 …
Property Management Service Market was valued at approximately USD 17.3 billion. It is anticipated to reach around USD 32.0 billion by 2033, growing at a compound annual growth rate (CAGR) of 7.3% from 2024 to 2033. Property Management Service Market Overview The Property Management Service Market is witnessing steady growth due to increasing urbanization, rising investments in real estate, and a growing demand for outsourced property management solutions. Property owners are increasingly
5G Chipset Market Set to Witness Significant Growth by 2033 | Apple Inc., HiSilicon Technologies Co., Ltd., ZTE Corporation,
5G Chipset Market Set to Witness Significant Growth by 2033 | Apple Inc., HiSili …
The global 5G chipset market was valued at USD 33.75 billion in 2024 and is projected to reach USD 502.66 billion by 2033, growing at a compound annual growth rate (CAGR) of 35% from 2025 to 2033. 5G Chipset Market Overview The 5G chipset market is experiencing rapid growth, driven by the global rollout of 5G networks and the increasing demand for high-speed, low-latency connectivity across various applications, including smartphones, IoT

All 5 Releases


More Releases for Macular

2025-2034 Macular Edema and Macular Degeneration Market Roadmap: Insights for Co …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts How Large Will the Macular Edema and Macular Degeneration Market Size By 2025? In the past few years, the market size for macular edema and macular degeneration has seen significant growth. It is projected to increase from $9.65 billion in 2024 to $10.43 billion in 2025, exhibiting a compound
Macular Edema and Macular Degeneration Market Poised for 7.1% Growth, Set to Hit …
How Are the key drivers contributing to the expansion of the macular edema and macular degeneration market? The growth of the macular edema and macular degeneration market is predicted to be driven by the escalating number of individuals suffering from diabetes. Diabetes is a long-term health condition that results in elevated levels of glucose in the bloodstream. The condition harms the eye's blood vessels, potentially leading to macular edema and macular
Macular Edema and Macular Degeneration Market Outlook 2025-2034: Key Trends, Gro …
"How Big Is the Macular Edema and Macular Degeneration Market Expected to Be, and What Will Its Growth Rate Be? The macular edema and macular degeneration market has seen significant growth in recent years. It will expand from $9.65 billion in 2024 to $10.43 billion in 2025, with a CAGR of 8.1%. Factors contributing to this growth include the aging population, increasing diabetes prevalence, early diagnosis and awareness, global initiatives in
Macular Edema and Macular Degeneration Market to Reach $22.51 Billion by 2034
The global macular edema and macular degeneration market, valued at $10.33 billion in 2023, is on track to grow at a remarkable compound annual growth rate (CAGR) of 7.34%, reaching $22.51 billion by 2034. This substantial market expansion is being fueled by rising treatment innovations, an increasing global prevalence of related diseases, and a surge in technological advancements in diagnostics and therapies. Download White Paper: https://www.towardshealthcare.com/download-statistics/5375 Market Overview and Key Drivers The macular
Macular Edema and Macular Degeneration Market Size, Trends, Growth, Outlook 2024 …
"The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033. Macular Edema and Macular Degeneration Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance. The Market Size Is Expected To Reach $12.84
Macular Edema and Macular Degeneration Market: Key Trends, Competitor Analysis, …
"Exploring the Global Macular Edema and Macular Degeneration Market: A Comprehensive Overview Insights into Macular Edema and Macular Degeneration Market: Global Trends and Analysis Macular Edema and Macular Degeneration Industry - Key Market Dynamics and Trends The macular edema and macular degeneration market size has grown strongly in recent years. It will grow from $8.84 billion in 2023 to $9.65 billion in 2024 at a compound annual growth rate (CAGR) of 9.1%. The